Home › Arrhythmogenic Right Ventricular Dysplasia › Maryland
Arrhythmogenic Right Ventricular Dysplasia clinical trials in Maryland
3 studies for Arrhythmogenic Right Ventricular Dysplasia are looking for participants at sites in Maryland.
Cities in Maryland
A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM
- Johns Hopkins University, Baltimore
- Northshore University Healthsystem Research Institute, Columbia
RecruitingObservational study
Ages 18 to 65 · All sexes · Updated May 16, 2025 · NCT06976606Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
- Johns Hopkins University, Baltimore
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Feb 6, 2025 · NCT06228924Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- John Hopkins University School of Medicine, Baltimore
RecruitingObservational study
Ages 14 to 65 · All sexes · Updated Nov 1, 2024 · NCT06311708From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.